Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The science of selective estrogen receptor modulators: concept to clinical practice.

× No keyword cloud information.

21 in total

1. Estrogen directly modulates circadian rhythms of PER2 expression in the uterus.

Authors: Takahiro J Nakamura; Michael T Sellix; Michael Menaker; Gene D Block
Journal: Am J Physiol Endocrinol Metab Date: 2008-08-26 Impact factor: 4.310

2. HOXB7 Is an ERα Cofactor in the Activation of HER2 and Multiple ER Target Genes Leading to Endocrine Resistance.

Authors: Kideok Jin; Sunju Park; Wei Wen Teo; Preethi Korangath; Sean Soonweng Cho; Takahiro Yoshida; Balázs Győrffy; Chirayu Pankaj Goswami; Harikrishna Nakshatri; Leigh-Ann Cruz; Weiqiang Zhou; Hongkai Ji; Ying Su; Muhammad Ekram; Zhengsheng Wu; Tao Zhu; Kornelia Polyak; Saraswati Sukumar
Journal: Cancer Discov Date: 2015-07-15 Impact factor: 39.397

Review 3. Mechanisms of endocrine resistance in breast cancer.

Authors: C Kent Osborne; Rachel Schiff
Journal: Annu Rev Med Date: 2011 Impact factor: 13.739

4. Tamoxifen produces conditioned taste avoidance in male rats: an analysis of microstructural licking patterns and taste reactivity.

Authors: Melissa A Fudge; Martin Kavaliers; John-Paul Baird; Klaus-Peter Ossenkopp
Journal: Horm Behav Date: 2009-07-02 Impact factor: 3.587

Review 5. The NSABP Study of Tamoxifen and Raloxifene (STAR) trial.

Authors: Victor G Vogel
Journal: Expert Rev Anticancer Ther Date: 2009-01 Impact factor: 4.512

Review 6. The effects of tamoxifen on immunity.

Authors: S Behjati; M H Frank
Journal: Curr Med Chem Date: 2009 Impact factor: 4.530

7. Variants in tamoxifen metabolizing genes: a case-control study of contralateral breast cancer risk in the WECARE study.

Authors: Jennifer D Brooks; Sharon N Teraoka; Kathleen E Malone; Robert W Haile; Leslie Bernstein; Charles F Lynch; Lene Mellemkjær; David J Duggan; Anne S Reiner; Patrick Concannon; Katherine Schiermeyer; Juan Pablo Lewinger; Jonine L Bernstein; Jane C Figueiredo
Journal: Int J Mol Epidemiol Genet Date: 2013-03-18

Review 8. SERMs for the treatment and prevention of breast cancer.

Authors: Ramona F Swaby; Catherine G N Sharma; V Craig Jordan
Journal: Rev Endocr Metab Disord Date: 2007-09 Impact factor: 6.514

9. Managing the risk of invasive breast cancer in women at risk for breast cancer and osteoporosis: the role of raloxifene.

Authors: Victor G Vogel
Journal: Clin Interv Aging Date: 2008 Impact factor: 4.458

10. Targeting tyrosine-kinases and estrogen receptor abrogates resistance to endocrine therapy in breast cancer.

Authors: Shuying Liu; Xiaolong Meng; Huiqin Chen; Wenbin Liu; Todd Miller; Mandi Murph; Yiling Lu; Fan Zhang; Mihai Gagea; Carlos L Arteaga; Gordon B Mills; Funda Meric-Bernstam; Ana M González-Angulo
Journal: Oncotarget Date: 2014-10-15